
    
      i. randomized, open label, single-dose, two-treatment, three-period,partial replicate
      pharmacokinetic study of Lansoprazole 30 mg Capsules of Beijing Sihuan Pharm, comparing with
      that of Lansoprazole enteric-coated Capsules 30 mg of Takeda Pharmaceutical Company Limited
      in healthy, adult, human subjects under fasting conditions.

      ii. randomized, open label, single dose, two-period, pharmacokinetic study of Lansoprazole 30
      mg Capsules of Beijing Sihuan Pharm in healthy, adult, human subjects under fasting/fed
      conditions.
    
  